|
Volumn 14, Issue 2, 2015, Pages 83-
|
Regulatory watch: Innovation in biologic new molecular entities: 1986-2014
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL PRODUCT;
BIOSIMILAR AGENT;
NEW DRUG;
CELL FUSION;
COMPETITION;
DRUG APPROVAL;
DRUG CLASSIFICATION;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
GENETIC ENGINEERING;
NOTE;
PRIORITY JOURNAL;
UNITED STATES;
DRUG DEVELOPMENT;
GOVERNMENT REGULATION;
LEGISLATION AND JURISPRUDENCE;
MASS COMMUNICATION;
STANDARDS;
STATISTICS AND NUMERICAL DATA;
BIOLOGICAL PRODUCTS;
BIOSIMILAR PHARMACEUTICALS;
DIFFUSION OF INNOVATION;
DRUG APPROVAL;
DRUG DISCOVERY;
GOVERNMENT REGULATION;
LEGISLATION, DRUG;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84926066210
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4535 Document Type: Note |
Times cited : (34)
|
References (0)
|